Insider Stock Trading History of Federico Charles


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Federico Charles since year 2005. The trader's CIK number is 1213215. At the time of this reporting, Federico Charles is the Director of Biomimetic Therapeutics, Inc. . (stock ticker symbol BMTI). See this page for all insider trading activities at Biomimetic Therapeutics, Inc. .

Note that in the past FEDERICO CHARLES also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Federico Charles since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2013-03-01 BMTI Biomimetic Therapeutics, Inc. Option Ex 38,736 4.22 163,272
2012-08-03 MAKO Mako Surgical Corp. Buy 2,000 12.95 25,898
2010-05-13 STRC Sri Surgical Express Inc Buy 5,000 4.07 20,339
2008-08-18 PMII Power Medical Interventions, Inc. Buy 3,000 3.82 11,466
2008-03-28 BMTI Biomimetic Therapeutics, Inc. Buy 1,075 9.24 9,936
2008-02-20 MAKO Mako Surgical Corp. Buy 10,000 10.00 100,000
2006-12-05 OFIX Orthofix International N V Option Ex 43,800 40.40 1,769,520
2006-12-05 OFIX Orthofix International N V Sale 43,800 45.10 1,975,248
2006-08-30 OFIX Orthofix International N V Option Ex 125,100 17.88 2,236,162
2006-08-31 OFIX Orthofix International N V Option Ex 124,900 30.66 3,828,934
2006-08-30 OFIX Orthofix International N V Sale 125,100 39.82 4,981,356
2006-08-31 OFIX Orthofix International N V Sale 124,900 39.41 4,922,558
2006-03-08 OFIX Orthofix International N V Option Ex 2,500 17.88 44,687
2006-03-08 OFIX Orthofix International N V Sale 2,500 43.00 107,500
2006-03-03 OFIX Orthofix International N V Sale 3,100 43.60 135,160
2006-03-03 OFIX Orthofix International N V Option Ex 3,100 17.88 55,412

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Federico Charles (Director of Biomimetic Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.